Osteoporosis Treatment in Post-menopausal Women

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The study will be conducted to assess the depressive symptoms and related markers in the postmenopausal female after anti-osteoporosis treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Taichung Veterans General Hospital
• Treatments: Alendronate; Raloxifene Hydrochloride

Criteria

Inclusion Criteria:

• Postmenopausal female

• Osteoporosis

Exclusion Criteria:

• Psychological disorders